K Pharma (TSE:4896) Other Current Liabilities: 円73.53 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4896 K Pharma Inc TSE:4896
12 GF Score
Price 円750.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Other Current Liabilities?

K Pharma TSE:4896 12 Other Current Liabilities is 円73.53 Mil as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

K Pharma's other current liabilities for the quarter that ended in Dec. 2025 was 円73.53 Mil.

K Pharma's quarterly other current liabilities declined from Jun. 2025 (円83.64 Mil) to Sep. 2025 (円60.21 Mil) but then increased from Sep. 2025 (円60.21 Mil) to Dec. 2025 (円73.53 Mil).

K Pharma's annual other current liabilities declined from Dec. 2023 (円89.83 Mil) to Dec. 2024 (円51.52 Mil) but then increased from Dec. 2024 (円51.52 Mil) to Dec. 2025 (円73.53 Mil).

K Pharma Other Current Liabilities Related Terms

K Pharma Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for K Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Other Current Liabilities Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
20.22 21.74 89.83 51.52 73.53

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.99 83.64 60.21 73.53 69.88
TSE:4896
12GF Score
K Pharma Inc TSE:4896
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円73.53 Mil mean?
K Pharma (TSE:4896) has a Other Current Liabilities of 円73.53 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on K Pharma.
Is K Pharma's Other Current Liabilities too high?
K Pharma's current Other Current Liabilities is 円73.53 Mil. Overall, K Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Other Current Liabilities compare to VRTX and REGN?
K Pharma's Other Current Liabilities of 円73.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on K Pharma. K Pharma's current Other Current Liabilities is 円73.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Other Current Liabilities of 円73.53 Mil. The current Other Current Liabilities is 円73.53 Mil. K Pharma's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Other Current Liabilities is 円73.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
12GF Score

Get the complete analysis for TSE:4896

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円750.00
Price